Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation

The precise mechanism through which macroautophagy/autophagy affects psoriasis is poorly understood. Here, we found that keratinocyte (KC) autophagy, which was positively correlated with psoriatic severity in patients and mouse models and could be inhibited by mitogen-activated protein kinase (MAPK)...

Full description

Saved in:
Bibliographic Details
Published inAutophagy Vol. 17; no. 2; pp. 529 - 552
Main Authors Wang, Zhen, Zhou, Hong, Zheng, Huaping, Zhou, Xikun, Shen, Guobo, Teng, Xiu, Liu, Xiao, Zhang, Jun, Wei, Xiaoqiong, Hu, Zhonglan, Zeng, Fanlian, Hu, Yawen, Hu, Jing, Wang, Xiaoyan, Chen, Shuwen, Cheng, Juan, Zhang, Chen, Gui, Yiyue, Zou, Song, Hao, Yan, Zhao, Qixiang, Wu, Wenling, Zhou, Yifan, Cui, Kaijun, Huang, Nongyu, Wei, Yuquan, Li, Wei, Li, Jiong
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 01.02.2021
Subjects
Online AccessGet full text
ISSN1554-8627
1554-8635
1554-8635
DOI10.1080/15548627.2020.1725381

Cover

Abstract The precise mechanism through which macroautophagy/autophagy affects psoriasis is poorly understood. Here, we found that keratinocyte (KC) autophagy, which was positively correlated with psoriatic severity in patients and mouse models and could be inhibited by mitogen-activated protein kinase (MAPK) family inactivation. The impairment of autophagic flux alleviated psoriasisform inflammation. We also found that an autophagy-based unconventional secretory pathway (autosecretion) dependent on ATG5 (autophagy related 5) and GORASP2 (golgi reassembly stacking protein 2) promoted psoriasiform KC inflammation. Moreover, the alarmin HMGB1 (high mobility group box 1) was more effective than other autosecretory proteins in regulating psoriasiform cutaneous inflammation. HMGB1 neutralization in autophagy-efficient KCs eliminated the differences in psoriasiform inflammation between Krt14 +/+ -Atg5 f/f KCs and Krt14 Cre/+ -atg5 f/f KCs, and conversely, recombinant HMGB1 almost completely restored psoriasiform inflammation in Krt14 Cre/+ -atg5 f/f KCs in vivo. These results suggest that HMGB1-associated autosecretion plays a pivotal role in cutaneous inflammation. Finally, we demonstrated that Krt14 Cre/+ -hmgb1 f/f mice displayed attenuated psoriatic inflammation due to the essential crosstalk between KC-specific HMGB1-associated autosecretion and γδT cells. Thus, this study uncovered a novel autophagy mechanism in psoriasis pathogenesis, and the findings imply the clinical significance of investigating and treating psoriasis. Abbreviations: 3-MA: 3-methyladenine; ACTB: actin beta; AGER: advanced glycosylation end-product specific receptor; Anti-HMGB1: anti-HMGB1 neutralizing antibody; Anti-IL18: anti-IL18 neutralizing antibody; Anti-IL1B: anti-IL1B neutralizing antibody; ATG5: autophagy related 5; BAF: bafilomycin A 1 ; BECN1: beclin 1; CASP1: caspase 1; CCL: C-C motif chemokine ligand; CsA: cyclosporine A; ctrl shRNA: lentivirus harboring shRNA against control; CXCL: C-X-C motif chemokine ligand; DCs: dendritic cells; DMEM: dulbecco's modified Eagle's medium; ELISA: enzyme-linked immunosorbent assay; EM: electron microscopy; FBS: fetal bovine serum; GORASP2 shRNA: lentivirus harboring shRNA against GORASP2; GORASP2/GRASP55: golgi reassembly stacking protein 2; GR1: a composite epitope between LY6 (lymphocyte antigen 6 complex) locus C1 and LY6 locus G6D antigens; H&E: hematoxylin and eosin; HMGB1: high mobility group box 1; HMGB1 shRNA: lentivirus harboring shRNA against HMGB1; IFNG/IFN-γ: interferon gamma; IL17A: interleukin 17A; IL18: interleukin 18; IL1A/IL-1α: interleukin 1 alpha; IL1B/IL-1β: interleukin 1 beta; IL22/IL-22: interleukin 22; IL23A: interleukin 23 subunit alpha; IL23R: interleukin 23 receptor; IMQ: imiquimod; ITGAM/CD11B: integrin subunit alpha M; ITGAX/CD11C: integrin subunit alpha X; IVL: involucrin; KC: keratinocyte; KD: knockdown; KO: knockout; Krt14 +/+ -Atg5 f/f mice: mice bearing an Atg5 flox allele, in which exon 3 of the Atg5 gene is flanked by two loxP sites; Krt14 +/+ -Hmgb1 f/f : mice bearing an Hmgb1 flox allele, in which exon 2 to 4 of the Hmgb1 gene is flanked by two loxP sites; Krt14 Cre/+ -atg5 f/f mice: keratinocyte-specific atg5 knockout mice generated by mating Atg5-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt4; Krt14 Cre/+ -hmgb1 f/f mice: keratinocyte-specific hmgb1 knockout mice generated by mating Hmgb1-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt14; Krt14-Vegfa mice: mice expressing 164-amino acid Vegfa splice variant recombinase under the control of promoter of Krt14; LAMP1: lysosomal associated membrane protein 1; LDH: lactate dehydrogenase; LORICRIN: loricrin cornified envelope precursor protein; M5: TNF, IL1A, IL17A, IL22 and OSM in combination; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAPK: mitogen-activated protein kinase; MKI67: marker of proliferation Ki-67; MTT: thiazolyl blue tetrazolium bromide; NFKB/NF-κB: nuclear factor kappa B; NHEKs: primary normal human epidermal keratinocytes; NS: not significant; OSM: oncostatin M; PASI: psoriasis area and severity index; PtdIns3K: class III phosphatidylinositol 3-kinase; qRT-PCR: quantitative RT-PCR; RELA/p65: RELA proto-oncogene, NF-kB subunit; rHMGB1: recombinant HMGB1; rIL18: recombinant interleukin 18; rIL1B: recombinant interleukin 1 beta; S100A: S100 calcium binding protein A; SQSTM1/p62: sequestosome 1; T17: IL17A-producing T; TCR: T-cell receptor; tcrd KO mice: tcrd (T cell receptor delta chain) knockout mice, which show deficient receptor expression in all adult lymphoid and epithelial organs; TLR: toll-like receptor; TNF/TNF-α: tumor necrosis factor; WOR: wortmannin; WT: wild-type; γδT17 cells: IL17A-producing γδ T cells.
AbstractList The precise mechanism through which macroautophagy/autophagy affects psoriasis is poorly understood. Here, we found that keratinocyte (KC) autophagy, which was positively correlated with psoriatic severity in patients and mouse models and could be inhibited by mitogen-activated protein kinase (MAPK) family inactivation. The impairment of autophagic flux alleviated psoriasisform inflammation. We also found that an autophagy-based unconventional secretory pathway (autosecretion) dependent on ATG5 (autophagy related 5) and GORASP2 (golgi reassembly stacking protein 2) promoted psoriasiform KC inflammation. Moreover, the alarmin HMGB1 (high mobility group box 1) was more effective than other autosecretory proteins in regulating psoriasiform cutaneous inflammation. HMGB1 neutralization in autophagy-efficient KCs eliminated the differences in psoriasiform inflammation between KCs and KCs, and conversely, recombinant HMGB1 almost completely restored psoriasiform inflammation in KCs . These results suggest that HMGB1-associated autosecretion plays a pivotal role in cutaneous inflammation. Finally, we demonstrated that mice displayed attenuated psoriatic inflammation due to the essential crosstalk between KC-specific HMGB1-associated autosecretion and γδT cells. Thus, this study uncovered a novel autophagy mechanism in psoriasis pathogenesis, and the findings imply the clinical significance of investigating and treating psoriasis. 3-MA: 3-methyladenine; ACTB: actin beta; AGER: advanced glycosylation end-product specific receptor; Anti-HMGB1: anti-HMGB1 neutralizing antibody; Anti-IL18: anti-IL18 neutralizing antibody; Anti-IL1B: anti-IL1B neutralizing antibody; ATG5: autophagy related 5; BAF: bafilomycin A ; BECN1: beclin 1; CASP1: caspase 1; CCL: C-C motif chemokine ligand; CsA: cyclosporine A; ctrl shRNA: lentivirus harboring shRNA against control; CXCL: C-X-C motif chemokine ligand; DCs: dendritic cells; DMEM: dulbecco's modified Eagle's medium; ELISA: enzyme-linked immunosorbent assay; EM: electron microscopy; FBS: fetal bovine serum; shRNA: lentivirus harboring shRNA against ; GORASP2/GRASP55: golgi reassembly stacking protein 2; GR1: a composite epitope between LY6 (lymphocyte antigen 6 complex) locus C1 and LY6 locus G6D antigens; H&E: hematoxylin and eosin; HMGB1: high mobility group box 1; shRNA: lentivirus harboring shRNA against ; IFNG/IFN-γ: interferon gamma; IL17A: interleukin 17A; IL18: interleukin 18; IL1A/IL-1α: interleukin 1 alpha; IL1B/IL-1β: interleukin 1 beta; IL22/IL-22: interleukin 22; IL23A: interleukin 23 subunit alpha; IL23R: interleukin 23 receptor; IMQ: imiquimod; ITGAM/CD11B: integrin subunit alpha M; ITGAX/CD11C: integrin subunit alpha X; IVL: involucrin; KC: keratinocyte; KD: knockdown; KO: knockout; mice: mice bearing an allele, in which exon 3 of the gene is flanked by two loxP sites; : mice bearing an flox allele, in which exon 2 to 4 of the gene is flanked by two loxP sites; mice: keratinocyte-specific knockout mice generated by mating mice with mice expressing recombinase under the control of the promoter of mice: keratinocyte-specific knockout mice generated by mating mice with mice expressing recombinase under the control of the promoter of mice: mice expressing 164-amino acid splice variant recombinase under the control of promoter of ; LAMP1: lysosomal associated membrane protein 1; LDH: lactate dehydrogenase; LORICRIN: loricrin cornified envelope precursor protein; M5: TNF, IL1A, IL17A, IL22 and OSM in combination; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAPK: mitogen-activated protein kinase; MKI67: marker of proliferation Ki-67; MTT: thiazolyl blue tetrazolium bromide; NFKB/NF-κB: nuclear factor kappa B; NHEKs: primary normal human epidermal keratinocytes; NS: not significant; OSM: oncostatin M; PASI: psoriasis area and severity index; PtdIns3K: class III phosphatidylinositol 3-kinase; qRT-PCR: quantitative RT-PCR; RELA/p65: RELA proto-oncogene, NF-kB subunit; rHMGB1: recombinant HMGB1; rIL18: recombinant interleukin 18; rIL1B: recombinant interleukin 1 beta; S100A: S100 calcium binding protein A; SQSTM1/p62: sequestosome 1; T17: IL17A-producing T; TCR: T-cell receptor; KO mice: (T cell receptor delta chain) knockout mice, which show deficient receptor expression in all adult lymphoid and epithelial organs; TLR: toll-like receptor; TNF/TNF-α: tumor necrosis factor; WOR: wortmannin; WT: wild-type; γδT17 cells: IL17A-producing γδ T cells.
The precise mechanism through which macroautophagy/autophagy affects psoriasis is poorly understood. Here, we found that keratinocyte (KC) autophagy, which was positively correlated with psoriatic severity in patients and mouse models and could be inhibited by mitogen-activated protein kinase (MAPK) family inactivation. The impairment of autophagic flux alleviated psoriasisform inflammation. We also found that an autophagy-based unconventional secretory pathway (autosecretion) dependent on ATG5 (autophagy related 5) and GORASP2 (golgi reassembly stacking protein 2) promoted psoriasiform KC inflammation. Moreover, the alarmin HMGB1 (high mobility group box 1) was more effective than other autosecretory proteins in regulating psoriasiform cutaneous inflammation. HMGB1 neutralization in autophagy-efficient KCs eliminated the differences in psoriasiform inflammation between Krt14+/+-Atg5f/f KCs and Krt14Cre/+-atg5f/f KCs, and conversely, recombinant HMGB1 almost completely restored psoriasiform inflammation in Krt14Cre/+-atg5f/f KCs in vivo. These results suggest that HMGB1-associated autosecretion plays a pivotal role in cutaneous inflammation. Finally, we demonstrated that Krt14Cre/+-hmgb1f/f mice displayed attenuated psoriatic inflammation due to the essential crosstalk between KC-specific HMGB1-associated autosecretion and γδT cells. Thus, this study uncovered a novel autophagy mechanism in psoriasis pathogenesis, and the findings imply the clinical significance of investigating and treating psoriasis.Abbreviations: 3-MA: 3-methyladenine; ACTB: actin beta; AGER: advanced glycosylation end-product specific receptor; Anti-HMGB1: anti-HMGB1 neutralizing antibody; Anti-IL18: anti-IL18 neutralizing antibody; Anti-IL1B: anti-IL1B neutralizing antibody; ATG5: autophagy related 5; BAF: bafilomycin A1; BECN1: beclin 1; CASP1: caspase 1; CCL: C-C motif chemokine ligand; CsA: cyclosporine A; ctrl shRNA: lentivirus harboring shRNA against control; CXCL: C-X-C motif chemokine ligand; DCs: dendritic cells; DMEM: dulbecco's modified Eagle's medium; ELISA: enzyme-linked immunosorbent assay; EM: electron microscopy; FBS: fetal bovine serum; GORASP2 shRNA: lentivirus harboring shRNA against GORASP2; GORASP2/GRASP55: golgi reassembly stacking protein 2; GR1: a composite epitope between LY6 (lymphocyte antigen 6 complex) locus C1 and LY6 locus G6D antigens; H&E: hematoxylin and eosin; HMGB1: high mobility group box 1; HMGB1 shRNA: lentivirus harboring shRNA against HMGB1; IFNG/IFN-γ: interferon gamma; IL17A: interleukin 17A; IL18: interleukin 18; IL1A/IL-1α: interleukin 1 alpha; IL1B/IL-1β: interleukin 1 beta; IL22/IL-22: interleukin 22; IL23A: interleukin 23 subunit alpha; IL23R: interleukin 23 receptor; IMQ: imiquimod; ITGAM/CD11B: integrin subunit alpha M; ITGAX/CD11C: integrin subunit alpha X; IVL: involucrin; KC: keratinocyte; KD: knockdown; KO: knockout; Krt14+/+-Atg5f/f mice: mice bearing an Atg5 flox allele, in which exon 3 of the Atg5 gene is flanked by two loxP sites; Krt14+/+-Hmgb1f/f: mice bearing an Hmgb1 flox allele, in which exon 2 to 4 of the Hmgb1 gene is flanked by two loxP sites; Krt14Cre/+-atg5f/f mice: keratinocyte-specific atg5 knockout mice generated by mating Atg5-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt4; Krt14Cre/+-hmgb1f/f mice: keratinocyte-specific hmgb1 knockout mice generated by mating Hmgb1-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt14; Krt14-Vegfa mice: mice expressing 164-amino acid Vegfa splice variant recombinase under the control of promoter of Krt14; LAMP1: lysosomal associated membrane protein 1; LDH: lactate dehydrogenase; LORICRIN: loricrin cornified envelope precursor protein; M5: TNF, IL1A, IL17A, IL22 and OSM in combination; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAPK: mitogen-activated protein kinase; MKI67: marker of proliferation Ki-67; MTT: thiazolyl blue tetrazolium bromide; NFKB/NF-κB: nuclear factor kappa B; NHEKs: primary normal human epidermal keratinocytes; NS: not significant; OSM: oncostatin M; PASI: psoriasis area and severity index; PtdIns3K: class III phosphatidylinositol 3-kinase; qRT-PCR: quantitative RT-PCR; RELA/p65: RELA proto-oncogene, NF-kB subunit; rHMGB1: recombinant HMGB1; rIL18: recombinant interleukin 18; rIL1B: recombinant interleukin 1 beta; S100A: S100 calcium binding protein A; SQSTM1/p62: sequestosome 1; T17: IL17A-producing T; TCR: T-cell receptor; tcrd KO mice: tcrd (T cell receptor delta chain) knockout mice, which show deficient receptor expression in all adult lymphoid and epithelial organs; TLR: toll-like receptor; TNF/TNF-α: tumor necrosis factor; WOR: wortmannin; WT: wild-type; γδT17 cells: IL17A-producing γδ T cells.The precise mechanism through which macroautophagy/autophagy affects psoriasis is poorly understood. Here, we found that keratinocyte (KC) autophagy, which was positively correlated with psoriatic severity in patients and mouse models and could be inhibited by mitogen-activated protein kinase (MAPK) family inactivation. The impairment of autophagic flux alleviated psoriasisform inflammation. We also found that an autophagy-based unconventional secretory pathway (autosecretion) dependent on ATG5 (autophagy related 5) and GORASP2 (golgi reassembly stacking protein 2) promoted psoriasiform KC inflammation. Moreover, the alarmin HMGB1 (high mobility group box 1) was more effective than other autosecretory proteins in regulating psoriasiform cutaneous inflammation. HMGB1 neutralization in autophagy-efficient KCs eliminated the differences in psoriasiform inflammation between Krt14+/+-Atg5f/f KCs and Krt14Cre/+-atg5f/f KCs, and conversely, recombinant HMGB1 almost completely restored psoriasiform inflammation in Krt14Cre/+-atg5f/f KCs in vivo. These results suggest that HMGB1-associated autosecretion plays a pivotal role in cutaneous inflammation. Finally, we demonstrated that Krt14Cre/+-hmgb1f/f mice displayed attenuated psoriatic inflammation due to the essential crosstalk between KC-specific HMGB1-associated autosecretion and γδT cells. Thus, this study uncovered a novel autophagy mechanism in psoriasis pathogenesis, and the findings imply the clinical significance of investigating and treating psoriasis.Abbreviations: 3-MA: 3-methyladenine; ACTB: actin beta; AGER: advanced glycosylation end-product specific receptor; Anti-HMGB1: anti-HMGB1 neutralizing antibody; Anti-IL18: anti-IL18 neutralizing antibody; Anti-IL1B: anti-IL1B neutralizing antibody; ATG5: autophagy related 5; BAF: bafilomycin A1; BECN1: beclin 1; CASP1: caspase 1; CCL: C-C motif chemokine ligand; CsA: cyclosporine A; ctrl shRNA: lentivirus harboring shRNA against control; CXCL: C-X-C motif chemokine ligand; DCs: dendritic cells; DMEM: dulbecco's modified Eagle's medium; ELISA: enzyme-linked immunosorbent assay; EM: electron microscopy; FBS: fetal bovine serum; GORASP2 shRNA: lentivirus harboring shRNA against GORASP2; GORASP2/GRASP55: golgi reassembly stacking protein 2; GR1: a composite epitope between LY6 (lymphocyte antigen 6 complex) locus C1 and LY6 locus G6D antigens; H&E: hematoxylin and eosin; HMGB1: high mobility group box 1; HMGB1 shRNA: lentivirus harboring shRNA against HMGB1; IFNG/IFN-γ: interferon gamma; IL17A: interleukin 17A; IL18: interleukin 18; IL1A/IL-1α: interleukin 1 alpha; IL1B/IL-1β: interleukin 1 beta; IL22/IL-22: interleukin 22; IL23A: interleukin 23 subunit alpha; IL23R: interleukin 23 receptor; IMQ: imiquimod; ITGAM/CD11B: integrin subunit alpha M; ITGAX/CD11C: integrin subunit alpha X; IVL: involucrin; KC: keratinocyte; KD: knockdown; KO: knockout; Krt14+/+-Atg5f/f mice: mice bearing an Atg5 flox allele, in which exon 3 of the Atg5 gene is flanked by two loxP sites; Krt14+/+-Hmgb1f/f: mice bearing an Hmgb1 flox allele, in which exon 2 to 4 of the Hmgb1 gene is flanked by two loxP sites; Krt14Cre/+-atg5f/f mice: keratinocyte-specific atg5 knockout mice generated by mating Atg5-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt4; Krt14Cre/+-hmgb1f/f mice: keratinocyte-specific hmgb1 knockout mice generated by mating Hmgb1-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt14; Krt14-Vegfa mice: mice expressing 164-amino acid Vegfa splice variant recombinase under the control of promoter of Krt14; LAMP1: lysosomal associated membrane protein 1; LDH: lactate dehydrogenase; LORICRIN: loricrin cornified envelope precursor protein; M5: TNF, IL1A, IL17A, IL22 and OSM in combination; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAPK: mitogen-activated protein kinase; MKI67: marker of proliferation Ki-67; MTT: thiazolyl blue tetrazolium bromide; NFKB/NF-κB: nuclear factor kappa B; NHEKs: primary normal human epidermal keratinocytes; NS: not significant; OSM: oncostatin M; PASI: psoriasis area and severity index; PtdIns3K: class III phosphatidylinositol 3-kinase; qRT-PCR: quantitative RT-PCR; RELA/p65: RELA proto-oncogene, NF-kB subunit; rHMGB1: recombinant HMGB1; rIL18: recombinant interleukin 18; rIL1B: recombinant interleukin 1 beta; S100A: S100 calcium binding protein A; SQSTM1/p62: sequestosome 1; T17: IL17A-producing T; TCR: T-cell receptor; tcrd KO mice: tcrd (T cell receptor delta chain) knockout mice, which show deficient receptor expression in all adult lymphoid and epithelial organs; TLR: toll-like receptor; TNF/TNF-α: tumor necrosis factor; WOR: wortmannin; WT: wild-type; γδT17 cells: IL17A-producing γδ T cells.
The precise mechanism through which macroautophagy/autophagy affects psoriasis is poorly understood. Here, we found that keratinocyte (KC) autophagy, which was positively correlated with psoriatic severity in patients and mouse models and could be inhibited by mitogen-activated protein kinase (MAPK) family inactivation. The impairment of autophagic flux alleviated psoriasisform inflammation. We also found that an autophagy-based unconventional secretory pathway (autosecretion) dependent on ATG5 (autophagy related 5) and GORASP2 (golgi reassembly stacking protein 2) promoted psoriasiform KC inflammation. Moreover, the alarmin HMGB1 (high mobility group box 1) was more effective than other autosecretory proteins in regulating psoriasiform cutaneous inflammation. HMGB1 neutralization in autophagy-efficient KCs eliminated the differences in psoriasiform inflammation between Krt14+/+-Atg5f/f KCs and Krt14Cre/+-atg5f/f KCs, and conversely, recombinant HMGB1 almost completely restored psoriasiform inflammation in Krt14Cre/+-atg5f/f KCs in vivo. These results suggest that HMGB1-associated autosecretion plays a pivotal role in cutaneous inflammation. Finally, we demonstrated that Krt14Cre/+-hmgb1f/f mice displayed attenuated psoriatic inflammation due to the essential crosstalk between KC-specific HMGB1-associated autosecretion and γδT cells. Thus, this study uncovered a novel autophagy mechanism in psoriasis pathogenesis, and the findings imply the clinical significance of investigating and treating psoriasis. Abbreviations: 3-MA: 3-methyladenine; ACTB: actin beta; AGER: advanced glycosylation end-product specific receptor; Anti-HMGB1: anti-HMGB1 neutralizing antibody; Anti-IL18: anti-IL18 neutralizing antibody; Anti-IL1B: anti-IL1B neutralizing antibody; ATG5: autophagy related 5; BAF: bafilomycin A1; BECN1: beclin 1; CASP1: caspase 1; CCL: C-C motif chemokine ligand; CsA: cyclosporine A; ctrl shRNA: lentivirus harboring shRNA against control; CXCL: C-X-C motif chemokine ligand; DCs: dendritic cells; DMEM: dulbecco’s modified Eagle’s medium; ELISA: enzyme-linked immunosorbent assay; EM: electron microscopy; FBS: fetal bovine serum; GORASP2 shRNA: lentivirus harboring shRNA against GORASP2; GORASP2/GRASP55: golgi reassembly stacking protein 2; GR1: a composite epitope between LY6 (lymphocyte antigen 6 complex) locus C1 and LY6 locus G6D antigens; H&E: hematoxylin and eosin; HMGB1: high mobility group box 1; HMGB1 shRNA: lentivirus harboring shRNA against HMGB1; IFNG/IFN-γ: interferon gamma; IL17A: interleukin 17A; IL18: interleukin 18; IL1A/IL-1α: interleukin 1 alpha; IL1B/IL-1β: interleukin 1 beta; IL22/IL-22: interleukin 22; IL23A: interleukin 23 subunit alpha; IL23R: interleukin 23 receptor; IMQ: imiquimod; ITGAM/CD11B: integrin subunit alpha M; ITGAX/CD11C: integrin subunit alpha X; IVL: involucrin; KC: keratinocyte; KD: knockdown; KO: knockout; Krt14+/+-Atg5f/f mice: mice bearing an Atg5 flox allele, in which exon 3 of the Atg5 gene is flanked by two loxP sites; Krt14+/+-Hmgb1f/f: mice bearing an Hmgb1 flox allele, in which exon 2 to 4 of the Hmgb1 gene is flanked by two loxP sites; Krt14Cre/+-atg5f/f mice: keratinocyte-specific atg5 knockout mice generated by mating Atg5-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt4; Krt14Cre/+-hmgb1f/f mice: keratinocyte-specific hmgb1 knockout mice generated by mating Hmgb1-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt14; Krt14-Vegfa mice: mice expressing 164-amino acid Vegfa splice variant recombinase under the control of promoter of Krt14; LAMP1: lysosomal associated membrane protein 1; LDH: lactate dehydrogenase; LORICRIN: loricrin cornified envelope precursor protein; M5: TNF, IL1A, IL17A, IL22 and OSM in combination; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAPK: mitogen-activated protein kinase; MKI67: marker of proliferation Ki-67; MTT: thiazolyl blue tetrazolium bromide; NFKB/NF-κB: nuclear factor kappa B; NHEKs: primary normal human epidermal keratinocytes; NS: not significant; OSM: oncostatin M; PASI: psoriasis area and severity index; PtdIns3K: class III phosphatidylinositol 3-kinase; qRT-PCR: quantitative RT-PCR; RELA/p65: RELA proto-oncogene, NF-kB subunit; rHMGB1: recombinant HMGB1; rIL18: recombinant interleukin 18; rIL1B: recombinant interleukin 1 beta; S100A: S100 calcium binding protein A; SQSTM1/p62: sequestosome 1; T17: IL17A-producing T; TCR: T-cell receptor; tcrd KO mice: tcrd (T cell receptor delta chain) knockout mice, which show deficient receptor expression in all adult lymphoid and epithelial organs; TLR: toll-like receptor; TNF/TNF-α: tumor necrosis factor; WOR: wortmannin; WT: wild-type; γδT17 cells: IL17A-producing γδ T cells.
The precise mechanism through which macroautophagy/autophagy affects psoriasis is poorly understood. Here, we found that keratinocyte (KC) autophagy, which was positively correlated with psoriatic severity in patients and mouse models and could be inhibited by mitogen-activated protein kinase (MAPK) family inactivation. The impairment of autophagic flux alleviated psoriasisform inflammation. We also found that an autophagy-based unconventional secretory pathway (autosecretion) dependent on ATG5 (autophagy related 5) and GORASP2 (golgi reassembly stacking protein 2) promoted psoriasiform KC inflammation. Moreover, the alarmin HMGB1 (high mobility group box 1) was more effective than other autosecretory proteins in regulating psoriasiform cutaneous inflammation. HMGB1 neutralization in autophagy-efficient KCs eliminated the differences in psoriasiform inflammation between Krt14 +/+ -Atg5 f/f KCs and Krt14 Cre/+ -atg5 f/f KCs, and conversely, recombinant HMGB1 almost completely restored psoriasiform inflammation in Krt14 Cre/+ -atg5 f/f KCs in vivo. These results suggest that HMGB1-associated autosecretion plays a pivotal role in cutaneous inflammation. Finally, we demonstrated that Krt14 Cre/+ -hmgb1 f/f mice displayed attenuated psoriatic inflammation due to the essential crosstalk between KC-specific HMGB1-associated autosecretion and γδT cells. Thus, this study uncovered a novel autophagy mechanism in psoriasis pathogenesis, and the findings imply the clinical significance of investigating and treating psoriasis. Abbreviations: 3-MA: 3-methyladenine; ACTB: actin beta; AGER: advanced glycosylation end-product specific receptor; Anti-HMGB1: anti-HMGB1 neutralizing antibody; Anti-IL18: anti-IL18 neutralizing antibody; Anti-IL1B: anti-IL1B neutralizing antibody; ATG5: autophagy related 5; BAF: bafilomycin A 1 ; BECN1: beclin 1; CASP1: caspase 1; CCL: C-C motif chemokine ligand; CsA: cyclosporine A; ctrl shRNA: lentivirus harboring shRNA against control; CXCL: C-X-C motif chemokine ligand; DCs: dendritic cells; DMEM: dulbecco's modified Eagle's medium; ELISA: enzyme-linked immunosorbent assay; EM: electron microscopy; FBS: fetal bovine serum; GORASP2 shRNA: lentivirus harboring shRNA against GORASP2; GORASP2/GRASP55: golgi reassembly stacking protein 2; GR1: a composite epitope between LY6 (lymphocyte antigen 6 complex) locus C1 and LY6 locus G6D antigens; H&E: hematoxylin and eosin; HMGB1: high mobility group box 1; HMGB1 shRNA: lentivirus harboring shRNA against HMGB1; IFNG/IFN-γ: interferon gamma; IL17A: interleukin 17A; IL18: interleukin 18; IL1A/IL-1α: interleukin 1 alpha; IL1B/IL-1β: interleukin 1 beta; IL22/IL-22: interleukin 22; IL23A: interleukin 23 subunit alpha; IL23R: interleukin 23 receptor; IMQ: imiquimod; ITGAM/CD11B: integrin subunit alpha M; ITGAX/CD11C: integrin subunit alpha X; IVL: involucrin; KC: keratinocyte; KD: knockdown; KO: knockout; Krt14 +/+ -Atg5 f/f mice: mice bearing an Atg5 flox allele, in which exon 3 of the Atg5 gene is flanked by two loxP sites; Krt14 +/+ -Hmgb1 f/f : mice bearing an Hmgb1 flox allele, in which exon 2 to 4 of the Hmgb1 gene is flanked by two loxP sites; Krt14 Cre/+ -atg5 f/f mice: keratinocyte-specific atg5 knockout mice generated by mating Atg5-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt4; Krt14 Cre/+ -hmgb1 f/f mice: keratinocyte-specific hmgb1 knockout mice generated by mating Hmgb1-floxed mice with mice expressing Cre recombinase under the control of the promoter of Krt14; Krt14-Vegfa mice: mice expressing 164-amino acid Vegfa splice variant recombinase under the control of promoter of Krt14; LAMP1: lysosomal associated membrane protein 1; LDH: lactate dehydrogenase; LORICRIN: loricrin cornified envelope precursor protein; M5: TNF, IL1A, IL17A, IL22 and OSM in combination; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAPK: mitogen-activated protein kinase; MKI67: marker of proliferation Ki-67; MTT: thiazolyl blue tetrazolium bromide; NFKB/NF-κB: nuclear factor kappa B; NHEKs: primary normal human epidermal keratinocytes; NS: not significant; OSM: oncostatin M; PASI: psoriasis area and severity index; PtdIns3K: class III phosphatidylinositol 3-kinase; qRT-PCR: quantitative RT-PCR; RELA/p65: RELA proto-oncogene, NF-kB subunit; rHMGB1: recombinant HMGB1; rIL18: recombinant interleukin 18; rIL1B: recombinant interleukin 1 beta; S100A: S100 calcium binding protein A; SQSTM1/p62: sequestosome 1; T17: IL17A-producing T; TCR: T-cell receptor; tcrd KO mice: tcrd (T cell receptor delta chain) knockout mice, which show deficient receptor expression in all adult lymphoid and epithelial organs; TLR: toll-like receptor; TNF/TNF-α: tumor necrosis factor; WOR: wortmannin; WT: wild-type; γδT17 cells: IL17A-producing γδ T cells.
Author Cui, Kaijun
Zou, Song
Wang, Zhen
Li, Wei
Cheng, Juan
Liu, Xiao
Wu, Wenling
Zhao, Qixiang
Shen, Guobo
Huang, Nongyu
Hu, Yawen
Zhou, Xikun
Hu, Zhonglan
Li, Jiong
Zhang, Chen
Hao, Yan
Zhou, Yifan
Gui, Yiyue
Hu, Jing
Teng, Xiu
Zheng, Huaping
Chen, Shuwen
Wei, Yuquan
Zhou, Hong
Wang, Xiaoyan
Zhang, Jun
Wei, Xiaoqiong
Zeng, Fanlian
Author_xml – sequence: 1
  givenname: Zhen
  surname: Wang
  fullname: Wang, Zhen
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 2
  givenname: Hong
  surname: Zhou
  fullname: Zhou, Hong
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 3
  givenname: Huaping
  surname: Zheng
  fullname: Zheng, Huaping
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 4
  givenname: Xikun
  orcidid: 0000-0001-6768-2382
  surname: Zhou
  fullname: Zhou, Xikun
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 5
  givenname: Guobo
  surname: Shen
  fullname: Shen, Guobo
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 6
  givenname: Xiu
  surname: Teng
  fullname: Teng, Xiu
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 7
  givenname: Xiao
  surname: Liu
  fullname: Liu, Xiao
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 8
  givenname: Jun
  surname: Zhang
  fullname: Zhang, Jun
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 9
  givenname: Xiaoqiong
  orcidid: 0000-0001-7576-4820
  surname: Wei
  fullname: Wei, Xiaoqiong
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 10
  givenname: Zhonglan
  surname: Hu
  fullname: Hu, Zhonglan
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 11
  givenname: Fanlian
  surname: Zeng
  fullname: Zeng, Fanlian
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 12
  givenname: Yawen
  surname: Hu
  fullname: Hu, Yawen
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 13
  givenname: Jing
  surname: Hu
  fullname: Hu, Jing
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 14
  givenname: Xiaoyan
  surname: Wang
  fullname: Wang, Xiaoyan
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 15
  givenname: Shuwen
  surname: Chen
  fullname: Chen, Shuwen
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 16
  givenname: Juan
  surname: Cheng
  fullname: Cheng, Juan
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 17
  givenname: Chen
  surname: Zhang
  fullname: Zhang, Chen
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 18
  givenname: Yiyue
  surname: Gui
  fullname: Gui, Yiyue
  organization: Sichuan University
– sequence: 19
  givenname: Song
  orcidid: 0000-0002-7219-3425
  surname: Zou
  fullname: Zou, Song
  organization: Sichuan University
– sequence: 20
  givenname: Yan
  surname: Hao
  fullname: Hao, Yan
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 21
  givenname: Qixiang
  surname: Zhao
  fullname: Zhao, Qixiang
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 22
  givenname: Wenling
  surname: Wu
  fullname: Wu, Wenling
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 23
  givenname: Yifan
  surname: Zhou
  fullname: Zhou, Yifan
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 24
  givenname: Kaijun
  surname: Cui
  fullname: Cui, Kaijun
  organization: Sichuan University
– sequence: 25
  givenname: Nongyu
  surname: Huang
  fullname: Huang, Nongyu
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 26
  givenname: Yuquan
  surname: Wei
  fullname: Wei, Yuquan
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
– sequence: 27
  givenname: Wei
  surname: Li
  fullname: Li, Wei
  organization: Sichuan University
– sequence: 28
  givenname: Jiong
  surname: Li
  fullname: Li, Jiong
  email: lijionghh@scu.edu.cn
  organization: West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32019420$$D View this record in MEDLINE/PubMed
BookMark eNqNkctu1DAUhiNURC_wCCAv2aT4EjseISFKBS1SERtYWyeO05o6drCTGWXL8_BufYU6zLRcFsDKx8f_9x_792Gx54M3RfGU4GOCJX5BOK-koPUxxTS3asqZJA-Kg6VfSsH43n1N6_3iMKUvGDMhV_RRsc8oJquK4oNiczKNYbiCy7lsIJkWTV4HvzZ-tMGDQ8noaJYahQ6dfzh7Q1Azo2sTYbQ-6Hk0CQ0O5oQADXYdxszE4AyyHg0pRJt1GqXrvLX-5vs36HtY7B4XDztwyTzZrUfF53dvP52elxcfz96fnlyUmrNqLLnBrOOdllVHJW3pShjGsGyYbqHFIGupqWxEJTrRiJq2XFS8xoIbQbTJr2RHhdj6Tn6AeQPOqSHaHuKsCFZLkuouSbUkqXZJZvDVFhympjetzolE-AkHsOr3E2-v1GVYK4lxTcQy-fnOIIavk0mj6m3SxjnwJkxJUcYJJyvKRZY--3XW_ZC7b8oCvhXoGFKKpvvvR7z8g9N2_JF_vrJ1_6Rfb2nruxB72IToWjXC7ELsInhtk2J_t7gF4qfOBA
CitedBy_id crossref_primary_10_3390_ijms25020771
crossref_primary_10_1002_pmic_202300184
crossref_primary_10_1016_j_intimp_2023_110221
crossref_primary_10_1016_j_jprot_2024_105195
crossref_primary_10_1186_s12915_021_01058_5
crossref_primary_10_3390_biomedicines11041130
crossref_primary_10_1016_j_intimp_2024_112244
crossref_primary_10_1016_j_biopha_2023_114421
crossref_primary_10_1016_j_intimp_2023_111397
crossref_primary_10_3390_ijms25105387
crossref_primary_10_7717_peerj_11278
crossref_primary_10_1016_j_clim_2024_110308
crossref_primary_10_1016_j_canlet_2023_216494
crossref_primary_10_1038_s41419_023_06094_3
crossref_primary_10_1007_s00403_024_03219_2
crossref_primary_10_12677_HJBM_2022_123018
crossref_primary_10_1111_php_13863
crossref_primary_10_1038_s41420_022_01228_6
crossref_primary_10_1038_s41577_023_00894_6
crossref_primary_10_1038_s41419_021_04181_x
crossref_primary_10_1080_15569527_2022_2127750
crossref_primary_10_3389_fmed_2024_1335551
crossref_primary_10_1038_s41392_022_01219_0
crossref_primary_10_1038_s41392_023_01655_6
crossref_primary_10_3389_fimmu_2021_714274
crossref_primary_10_1080_00207454_2024_2352781
crossref_primary_10_1111_exd_14909
crossref_primary_10_1186_s12964_024_01758_9
crossref_primary_10_2147_CCID_S476785
crossref_primary_10_1016_j_jbc_2024_105677
crossref_primary_10_3390_biom11091334
crossref_primary_10_3390_ani13010092
crossref_primary_10_1002_advs_202205462
crossref_primary_10_1111_jocd_15282
crossref_primary_10_3390_biom12010060
crossref_primary_10_1039_D2BM01586B
crossref_primary_10_1111_exd_15159
crossref_primary_10_1080_15548627_2021_2008692
crossref_primary_10_3892_or_2023_8653
crossref_primary_10_1016_j_canlet_2024_216621
crossref_primary_10_1111_bph_17349
crossref_primary_10_3389_fphar_2023_1092473
crossref_primary_10_1016_j_celrep_2024_114261
crossref_primary_10_1038_s41419_024_06583_z
crossref_primary_10_1080_08820139_2023_2288836
crossref_primary_10_1172_JCI156501
crossref_primary_10_1016_j_intimp_2023_110915
crossref_primary_10_1016_j_phymed_2024_155917
crossref_primary_10_2478_aite_2024_0005
crossref_primary_10_3390_ijms25116068
crossref_primary_10_1038_s41419_024_06514_y
crossref_primary_10_3389_fimmu_2024_1343987
crossref_primary_10_1021_acsomega_5c00336
crossref_primary_10_1038_s41419_022_05045_8
crossref_primary_10_1016_j_phymed_2023_155041
crossref_primary_10_1016_j_jdermsci_2022_07_005
crossref_primary_10_3390_cimb46040228
crossref_primary_10_2174_0113894501277656231128060242
crossref_primary_10_1007_s00018_024_05433_7
crossref_primary_10_1002_advs_202400107
crossref_primary_10_3389_fcell_2021_672847
crossref_primary_10_1038_s41419_022_04591_5
crossref_primary_10_1177_15330338241307686
crossref_primary_10_1186_s43556_024_00178_y
crossref_primary_10_1186_s12967_024_04932_2
crossref_primary_10_1016_j_jid_2022_10_020
crossref_primary_10_1016_j_jid_2023_12_023
crossref_primary_10_1097_JD9_0000000000000353
crossref_primary_10_1111_bph_15983
crossref_primary_10_1002_cjoc_202300649
crossref_primary_10_1016_j_jnutbio_2025_109890
crossref_primary_10_2147_PTT_S327310
crossref_primary_10_3390_cells11152410
crossref_primary_10_1002_med_21884
crossref_primary_10_1038_s41419_022_04523_3
crossref_primary_10_1016_j_mce_2021_111417
crossref_primary_10_1186_s13578_024_01238_0
crossref_primary_10_1111_1346_8138_16874
crossref_primary_10_1681_ASN_0000000000000024
crossref_primary_10_3390_molecules27072361
crossref_primary_10_1016_j_intimp_2024_112704
crossref_primary_10_1016_j_ijbiomac_2022_12_299
crossref_primary_10_1016_j_jid_2021_05_016
crossref_primary_10_1016_j_tiv_2022_105378
crossref_primary_10_3389_fimmu_2024_1486627
crossref_primary_10_1039_D2FO02545K
crossref_primary_10_2147_CCID_S284300
crossref_primary_10_3389_fcell_2022_892450
crossref_primary_10_5826_dpc_1403a177
crossref_primary_10_1097_JD9_0000000000000297
crossref_primary_10_2147_CCID_S422355
crossref_primary_10_3390_cells13201675
crossref_primary_10_1016_j_intimp_2024_113508
crossref_primary_10_1021_acsnano_4c13533
crossref_primary_10_3389_fphar_2022_844756
crossref_primary_10_3390_cells11223691
crossref_primary_10_1111_1346_8138_16185
crossref_primary_10_1016_j_intimp_2023_110331
crossref_primary_10_1371_journal_ppat_1012133
crossref_primary_10_1080_14728222_2024_2375373
crossref_primary_10_1155_2023_3397940
crossref_primary_10_1016_j_biopha_2023_115246
crossref_primary_10_1016_j_heliyon_2024_e29859
crossref_primary_10_3389_fmed_2023_1292722
crossref_primary_10_1080_10985549_2024_2325527
crossref_primary_10_1371_journal_pone_0314873
crossref_primary_10_1016_j_molimm_2023_09_004
crossref_primary_10_1016_j_biopha_2021_112297
crossref_primary_10_1002_lary_31416
crossref_primary_10_1002_iid3_1205
crossref_primary_10_1016_j_freeradbiomed_2024_08_004
Cites_doi 10.1038/nature04724
10.1016/j.devcel.2018.03.023
10.1371/journal.pone.0135898
10.1016/j.canlet.2013.11.019
10.1016/j.jid.2019.02.021
10.1016/j.jid.2018.02.035
10.1016/j.chom.2017.10.008
10.1111/1346-8138.13695
10.1016/j.jaad.2004.04.012
10.1007/s40261-018-0656-y
10.1111/j.1440-1711.2006.01454.x
10.1080/15548627.2016.1159375
10.1242/jcs.176412
10.1038/nprot.2008.211
10.1146/annurev-immunol-032713-120225
10.1016/j.jid.2016.03.016
10.1016/j.molcel.2018.11.018
10.1038/ni.2215
10.1186/s13024-018-0273-5
10.1038/nri3532
10.1182/blood-2002-12-3793
10.4049/jimmunol.0902464
10.1016/j.mam.2014.05.001
10.1093/emboj/cdg516
10.1242/jcs.144816
10.1016/j.jid.2016.06.618
10.1007/s00403-014-1508-0
10.7150/thno.15584
10.1038/emboj.2011.398
10.18632/oncotarget.9330
10.4161/viru.2.2.15480
10.4049/jimmunol.1202495
10.1084/jem.20100559
10.1038/ncomms6779
10.1007/s00403-013-1330-0
10.1038/ni.3273
10.1007/s00430-010-0163-0
10.1016/j.immuni.2011.08.001
10.1038/ncomms8687
10.1038/cdd.2011.78
10.1038/ncb2979
10.1016/j.tcb.2012.04.008
10.1080/15548627.2017.1402992
10.1111/jdv.13564
10.1146/annurev-immunol-020711-074948
10.1172/JCI61862
10.1002/path.4848
10.1038/nprot.2009.241
10.1016/j.bbadis.2018.02.003
10.1080/15548627.2015.1100356
10.4049/jimmunol.0802999
10.4049/jimmunol.1001954
10.1111/j.1365-2133.1992.tb07805.x
10.18632/oncotarget.17885
10.1038/sj.cdd.4401984
10.15252/embj.201695081
10.1016/j.immuni.2009.08.001
10.1016/j.cyto.2011.08.022
10.1111/j.1346-8138.2011.01458.x
10.1016/S0140-6736(18)30485-9
10.4049/jimmunol.1300047
10.1016/j.bbrc.2014.11.038
10.1038/jid.2012.318
10.3389/fphys.2015.00093
10.1007/s00018-011-0702-x
10.3389/fimmu.2018.01512
10.1038/nri2622
10.1038/onc.2012.631
10.1016/j.molcel.2009.04.026
10.2340/00015555-1183
10.1038/nrrheum.2011.222
10.1016/j.bcp.2016.06.001
10.1038/emboj.2010.74
10.1083/jcb.200911078
10.1038/nprot.2008.50
10.4049/jimmunol.1303297
10.1146/annurev-immunol-030409-101323
10.1016/j.immuni.2012.04.008
ContentType Journal Article
Copyright 2020 Informa UK Limited, trading as Taylor & Francis Group 2020
2020 Informa UK Limited, trading as Taylor & Francis Group 2020 Informa UK Limited, trading as Taylor & Francis Group
Copyright_xml – notice: 2020 Informa UK Limited, trading as Taylor & Francis Group 2020
– notice: 2020 Informa UK Limited, trading as Taylor & Francis Group 2020 Informa UK Limited, trading as Taylor & Francis Group
DBID AAYXX
CITATION
NPM
7X8
5PM
ADTOC
UNPAY
DOI 10.1080/15548627.2020.1725381
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Z. WANG ET AL
EISSN 1554-8635
EndPage 552
ExternalDocumentID 10.1080/15548627.2020.1725381
PMC8007160
32019420
10_1080_15548627_2020_1725381
1725381
Genre Research Article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0BK
0R~
23N
30N
4.4
53G
5GY
AAGDL
AAHIA
AAJMT
AALDU
AAMIU
AAPUL
AAQRR
ABCCY
ABFIM
ABJNI
ABLIJ
ABPAQ
ABPEM
ABTAI
ABXUL
ABXYU
ACGFS
ACTIO
ADBBV
ADCVX
ADGTB
ADHGD
AEISY
AENEX
AEYOC
AFRVT
AGDLA
AHDZW
AIJEM
AIYEW
AKBVH
AKOOK
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AOIJS
AQRUH
AQTUD
AVBZW
AWYRJ
BAWUL
BLEHA
CCCUG
DGEBU
DIK
DKSSO
E3Z
EBS
EMOBN
F5P
GTTXZ
H13
HYE
IPNFZ
KYCEM
LJTGL
M4Z
O9-
OK1
P2P
RIG
RNANH
ROSJB
RPM
RTWRZ
SNACF
TASJS
TBQAZ
TDBHL
TEI
TFL
TFT
TFW
TQWBC
TR2
TTHFI
TUROJ
ZGOLN
AAYXX
CITATION
AAGME
ABFMO
ACDHJ
ACZPZ
ADOPC
ADYSH
AURDB
BFWEY
C1A
CWRZV
EJD
NPM
PCLFJ
7X8
5PM
ACFTK
ADTOC
UNPAY
ID FETCH-LOGICAL-c534t-5e03f5fc84f282d296e3308b3cdad0a878c28b646f6b672d56457065e61ce3203
IEDL.DBID UNPAY
ISSN 1554-8627
1554-8635
IngestDate Sun Oct 26 04:07:54 EDT 2025
Tue Sep 30 17:04:46 EDT 2025
Thu Oct 02 06:09:21 EDT 2025
Mon Jul 21 05:28:20 EDT 2025
Thu Apr 24 23:07:45 EDT 2025
Wed Oct 01 03:29:25 EDT 2025
Mon Oct 20 23:49:13 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Alarmin
autophagy
secretion
keratinocytes
psoriasis
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c534t-5e03f5fc84f282d296e3308b3cdad0a878c28b646f6b672d56457065e61ce3203
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
Co-corresponding authors
ORCID 0000-0001-7576-4820
0000-0001-6768-2382
0000-0002-7219-3425
OpenAccessLink https://proxy.k.utb.cz/login?url=https://www.tandfonline.com/doi/pdf/10.1080/15548627.2020.1725381?needAccess=true
PMID 32019420
PQID 2351519256
PQPubID 23479
PageCount 24
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8007160
proquest_miscellaneous_2351519256
unpaywall_primary_10_1080_15548627_2020_1725381
informaworld_taylorfrancis_310_1080_15548627_2020_1725381
crossref_citationtrail_10_1080_15548627_2020_1725381
crossref_primary_10_1080_15548627_2020_1725381
pubmed_primary_32019420
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-02-01
PublicationDateYYYYMMDD 2021-02-01
PublicationDate_xml – month: 02
  year: 2021
  text: 2021-02-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Autophagy
PublicationTitleAlternate Autophagy
PublicationYear 2021
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References cit0033
cit0077
cit0034
cit0078
cit0031
cit0075
cit0032
cit0076
cit0073
cit0030
cit0074
cit0071
cit0072
cit0070
cit0037
cit0038
cit0035
cit0079
cit0036
cit0022
cit0066
cit0023
cit0067
cit0020
cit0064
cit0021
cit0065
cit0062
cit0063
cit0060
cit0061
cit0028
cit0029
cit0026
cit0027
cit0024
cit0068
cit0025
cit0069
cit0011
cit0055
cit0012
cit0056
cit0053
cit0010
cit0054
cit0051
cit0052
cit0050
Zhang M (cit0039) 2015
cit0019
cit0017
cit0018
cit0015
cit0059
cit0016
cit0013
cit0057
cit0014
cit0058
cit0044
cit0001
cit0045
cit0042
cit0043
cit0040
cit0041
cit0008
cit0009
cit0006
cit0007
cit0004
cit0048
cit0005
cit0049
cit0002
cit0046
cit0003
cit0047
References_xml – ident: cit0032
  doi: 10.1038/nature04724
– ident: cit0040
  doi: 10.1016/j.devcel.2018.03.023
– ident: cit0070
  doi: 10.1371/journal.pone.0135898
– ident: cit0051
  doi: 10.1016/j.canlet.2013.11.019
– ident: cit0053
  doi: 10.1016/j.jid.2019.02.021
– ident: cit0056
  doi: 10.1016/j.jid.2018.02.035
– ident: cit0077
  doi: 10.1016/j.chom.2017.10.008
– ident: cit0073
  doi: 10.1111/1346-8138.13695
– ident: cit0074
  doi: 10.1016/j.jaad.2004.04.012
– ident: cit0010
  doi: 10.1007/s40261-018-0656-y
– ident: cit0030
  doi: 10.1111/j.1440-1711.2006.01454.x
– ident: cit0038
  doi: 10.1080/15548627.2016.1159375
– ident: cit0062
  doi: 10.1242/jcs.176412
– ident: cit0036
  doi: 10.1038/nprot.2008.211
– ident: cit0001
  doi: 10.1146/annurev-immunol-032713-120225
– ident: cit0014
  doi: 10.1016/j.jid.2016.03.016
– ident: cit0007
  doi: 10.1016/j.molcel.2018.11.018
– ident: cit0042
  doi: 10.1038/ni.2215
– ident: cit0052
  doi: 10.1186/s13024-018-0273-5
– ident: cit0003
  doi: 10.1038/nri3532
– ident: cit0027
  doi: 10.1182/blood-2002-12-3793
– ident: cit0028
  doi: 10.4049/jimmunol.0902464
– ident: cit0072
  doi: 10.1016/j.mam.2014.05.001
– ident: cit0063
  doi: 10.1093/emboj/cdg516
– ident: cit0015
  doi: 10.1242/jcs.144816
– ident: cit0019
  doi: 10.1016/j.jid.2016.06.618
– ident: cit0016
  doi: 10.1007/s00403-014-1508-0
– ident: cit0061
  doi: 10.7150/thno.15584
– ident: cit0037
  doi: 10.1038/emboj.2011.398
– ident: cit0013
  doi: 10.18632/oncotarget.9330
– ident: cit0041
  doi: 10.4161/viru.2.2.15480
– ident: cit0068
  doi: 10.4049/jimmunol.1202495
– ident: cit0078
  doi: 10.1084/jem.20100559
– ident: cit0054
  doi: 10.1038/ncomms6779
– ident: cit0045
  doi: 10.1007/s00403-013-1330-0
– ident: cit0004
  doi: 10.1038/ni.3273
– ident: cit0017
  doi: 10.1007/s00430-010-0163-0
– ident: cit0033
  doi: 10.1016/j.immuni.2011.08.001
– ident: cit0079
  doi: 10.1038/ncomms8687
– ident: cit0006
  doi: 10.1038/cdd.2011.78
– ident: cit0059
  doi: 10.1038/ncb2979
– ident: cit0021
  doi: 10.1016/j.tcb.2012.04.008
– ident: cit0005
  doi: 10.1080/15548627.2017.1402992
– ident: cit0044
  doi: 10.1111/jdv.13564
– ident: cit0048
  doi: 10.1146/annurev-immunol-020711-074948
– ident: cit0034
  doi: 10.1172/JCI61862
– ident: cit0047
  doi: 10.1002/path.4848
– start-page: 4:e11205
  year: 2015
  ident: cit0039
  publication-title: eLife
– ident: cit0075
  doi: 10.1038/nprot.2009.241
– ident: cit0020
  doi: 10.1016/j.bbadis.2018.02.003
– ident: cit0024
  doi: 10.1080/15548627.2015.1100356
– ident: cit0026
  doi: 10.4049/jimmunol.0802999
– ident: cit0018
  doi: 10.4049/jimmunol.1001954
– ident: cit0022
  doi: 10.1111/j.1365-2133.1992.tb07805.x
– ident: cit0065
  doi: 10.18632/oncotarget.17885
– ident: cit0049
  doi: 10.1038/sj.cdd.4401984
– ident: cit0057
  doi: 10.15252/embj.201695081
– ident: cit0046
  doi: 10.1016/j.immuni.2009.08.001
– ident: cit0031
  doi: 10.1016/j.cyto.2011.08.022
– ident: cit0067
  doi: 10.1111/j.1346-8138.2011.01458.x
– ident: cit0009
  doi: 10.1016/S0140-6736(18)30485-9
– ident: cit0029
  doi: 10.4049/jimmunol.1300047
– ident: cit0050
  doi: 10.1016/j.bbrc.2014.11.038
– ident: cit0025
  doi: 10.1038/jid.2012.318
– ident: cit0071
  doi: 10.3389/fphys.2015.00093
– ident: cit0035
  doi: 10.1007/s00018-011-0702-x
– ident: cit0008
  doi: 10.3389/fimmu.2018.01512
– ident: cit0002
  doi: 10.1038/nri2622
– ident: cit0064
  doi: 10.1038/onc.2012.631
– ident: cit0058
  doi: 10.1016/j.molcel.2009.04.026
– ident: cit0011
  doi: 10.2340/00015555-1183
– ident: cit0043
  doi: 10.1038/nrrheum.2011.222
– ident: cit0012
  doi: 10.1016/j.bcp.2016.06.001
– ident: cit0023
  doi: 10.1038/emboj.2010.74
– ident: cit0060
  doi: 10.1083/jcb.200911078
– ident: cit0076
  doi: 10.1038/nprot.2008.50
– ident: cit0066
  doi: 10.4049/jimmunol.1303297
– ident: cit0069
  doi: 10.1146/annurev-immunol-030409-101323
– ident: cit0055
  doi: 10.1016/j.immuni.2012.04.008
SSID ssj0036892
Score 2.6211925
Snippet The precise mechanism through which macroautophagy/autophagy affects psoriasis is poorly understood. Here, we found that keratinocyte (KC) autophagy, which was...
SourceID unpaywall
pubmedcentral
proquest
pubmed
crossref
informaworld
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 529
SubjectTerms Alarmin
autophagy
keratinocytes
psoriasis
Research Paper
secretion
Title Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation
URI https://www.tandfonline.com/doi/abs/10.1080/15548627.2020.1725381
https://www.ncbi.nlm.nih.gov/pubmed/32019420
https://www.proquest.com/docview/2351519256
https://pubmed.ncbi.nlm.nih.gov/PMC8007160
https://www.tandfonline.com/doi/pdf/10.1080/15548627.2020.1725381?needAccess=true
UnpaywallVersion publishedVersion
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1554-8635
  dateEnd: 20241102
  omitProxy: true
  ssIdentifier: ssj0036892
  issn: 1554-8635
  databaseCode: DIK
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVLSH
  databaseName: aylor and Francis Online
  customDbUrl:
  mediaType: online
  eissn: 1554-8635
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0036892
  issn: 1554-8635
  databaseCode: AHDZW
  dateStart: 20050401
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1554-8635
  dateEnd: 20241102
  omitProxy: true
  ssIdentifier: ssj0036892
  issn: 1554-8635
  databaseCode: RPM
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVAWR
  databaseName: Taylor & Francis Science and Technology Library-DRAA
  customDbUrl:
  eissn: 1554-8635
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0036892
  issn: 1554-8635
  databaseCode: 30N
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: http://www.tandfonline.com/page/title-lists
  providerName: Taylor & Francis
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3bjtMwELV2u0Lwwv1SLisj8ZpuYjtO8oBQQSwV0lYgUWl5ihzHXqIWJ2oSVuGR7-Hf-AU8uZSWixYk3tKmU8WTsedMcnwGoSdMKFtYpcwhFgs7TCrmJKEWDqNcyzBQLmvbAZ3M-WzBXp_6p3vo7bAXBmiVUEPrTiiiXathchepHhhxR5ACLRAPbHVH7FcBsZPWe2bsaj9tmww-rda12kcH3LfwfIQOFvM30_etbqrPHDD8cUz9YVfPn_53J1_tqJn-DpP-Sq28XJtCNOditdrKW8fX0HoYcUdXWU7qKpnIzz-JQf5Xl1xHV3uUi6ddWN5Ae8rcRJe6vpfNLXQ-rUHPQJw1DmTRFNvkusV-xyVgWTjGucazk1fPPZw0eAn6z5nJZWPhMS5WoimxwEX2KbcFBAaaJM4MLsp8DeEmcbm0HzPz7esX8bHboHkbLY5fvnsxc_oOEI70KascX7lUA8uMaVsapiTiilI3TKhMReqKMAglCRPOuOYJD0gK0jjw3lZxTypKXHoHjUxu1D2EU8klCRRzk4gxV2gRhDplaSBoJBPqJ2PEhvscy14eHbp0rGKvV1EdfByDj-Pex2M02ZgVnT7IRQbRdhDFVftgRnddVGJ6ge3jIeJiuwrAqx1hVF6XMaEWl1qw7vMxuttF4OZyrB-8iBF3jIKd2Nz8ABTGd8-Y7EOrNB4CAuXW8mgTxX83yvv_bPEAXSFAF2oJ8Q_RCAL2kcV7VXKI9qk7P-zn8Xdr_Epe
linkProvider Unpaywall
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZQESqX8oblaSSu2WZtx0mOBVEW6O6plXqLbMcu0S5J1GRbhSO_h__GX2Amj9UuDxWptySbidaTceab5PM3hLwRykJhlQqPARb2hLHC05FTnuDSmSi0vmjbAc3mcnoiPp0GpxtrYZBWiTW064Qi2mc1Tm58GT1Q4vYxBwISD6G8Y3AoZDBroQK6GQDYxy4G3J8PT2Muo7YxMpp4aDOs4vnXZbby05Z66d8w6J9Uyt1VXqrmUi2XG3nq8A4xwwg7espivKr12Hz7Tfzxei64S_Z6GEsPuri7R27Y_D651TW2bB6Qy4MVChaos8bDNJlSyJ4b9HZaIVjFbVo4Op19eDuhuqELFHjO8sI0gH9puVRNRRUts4sCKgSKPEia5bSsinOMJ0OrBexm-c8f39XXbgXmQ3Jy-P743dTrWzx4JuCi9gLrc4c0MuGg9ktZLC3nfqS5SVXqqyiMDIu0FNJJLUOWovYNfpi1cmIsZz5_RHbyIrdPCE2NNCy0wtexEL5yKoxcKtJQ8dhoHugREcONTUyvf45tOJbJpJdJHXyaoE-T3qcjMl6blZ0AyFUG8WbUJHX75sV1bVISfoXt6yHEEpjm-O1G5bZYVQnjADwBjQdyRB53Ibf-O-CHSSyYPyLhVjCuT0AJ8e1f8uxLKyUeIcSUYLm_Dtv_G-XTa4zyFdmdHs-OkqOP88_PyG2GLKGWB_-c7NTnK_sCYF6tX7bz-BdxV0QW
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JjtNAEG2hQSwX9iWsjcTVGae703aOwxLCMhEHRuJm9QpWgm2NbUbmyPfwb_wCVV6ihEWDNDfHTkXuSrXrlfv1K0KeCuWgsLIiYICFA2GcCHTsVSC49CaOXCjadkCHS7k4Em8-Tgc2YdnTKrGG9p1QRPusxsldWD8w4vYxBQIQj6C6Y3AqYjBpoQA6L3FVDHdxhMvhYcxl3PZFRpMAbYZNPP_6mZ30tCNe-jcI-ieT8lKdFao5Uev1VpqaXyV6GGDHTlmN60qPzbfftB_P5IFr5EoPYulBF3XXyTmX3SAXuraWzU1yclCjXIH61ASYJC2F3LlFbqclQlU8prmni8NXzyZUN3SF8s5plpsG0C8t1qopqaJF-jWH-oAiC5KmGS3K_BijydByBR_T7OeP7-pLt__yFjmav_zwfBH0DR4CM-WiCqYu5B5JZMJD5WfZTDrOw1hzY5UNVRzFhsVaCumllhGzqHyDy7JOTozjLOS3yV6WZ-4uodZIwyInQj0TIlReRbG3wkaKz4zmUz0iYvhfE9Orn2MTjnUy6UVSB58m6NOk9-mIjDdmRSf_cZrBbDtokqp97-K7JikJP8X2yRBhCUxyXLlRmcvrMmEQ2AC1AZ6OyJ0u4ja3A36YzAQLRyTaicXNF1BAfPdKln5uhcRjBJgSLPc3Uft_o7x3hlE-Jhffv5gn714v394nlxlShFoS_AOyVx3X7iFgvEo_amfxLzc3Qro
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3bjtMwELWWrhC8cL-Um4zEa7qJ7TjpA0IFsVRIuwKJSstT5PiyRC1O1CSswiPfw7_xC3hyKS0XLUi8pU2niidjz5nk-AxCT5jQrrBSzCMOC3tMaualsREeo9zIONI-a9sBHR3z-YK9PglP9tDbYS8M0CqhhjadUES7VsPkLpQZGHEHkAIdEI9cdUfcVxFxkzZ4Zt1qP2ubDD6t1rW-gPZ56OD5CO0vjt_M3re6qSHzwPDHMQ2HXT1_-t-dfLWjZvo7TPortfJSbQvRnInVaitvHV5F62HEHV1lOamrdCI__yQG-V9dcg1d6VEunnVheR3taXsDXez6XjY30dmsBj0Dcdp4kEUVdsl1i_2OS8CycIxzg-dHr54HOG3wEvSfM5vLxsFjXKxEU2KBi-xT7goIDDRJnFlclPkawk3icuk-Zvbb1y_iY7dB8xZaHL5892Lu9R0gPBlSVnmh9qkBlhkzrjRUZMo1pX6cUqmE8kUcxZLEKWfc8JRHRIE0Dry31TyQmhKf3kYjm1t9F2EluSSRZn46ZcwXRkSxUUxFgk5lSsN0jNhwnxPZy6NDl45VEvQqqoOPE_Bx0vt4jCYbs6LTBznPYLodREnVPpgxXReVhJ5j-3iIuMStAvBqR1id12VCqMOlDqyHfIzudBG4uRznh2DKiD9G0U5sbn4ACuO7Z2z2oVUajwGBcmd5sInivxvlvX-2uI8uE6ALtYT4B2gEAfvQ4b0qfdTP4O-0H0mM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Autophagy-based+unconventional+secretion+of+HMGB1+by+keratinocytes+plays+a+pivotal+role+in+psoriatic+skin+in%EF%AC%82ammation&rft.jtitle=Autophagy&rft.au=Wang%2C+Zhen&rft.au=Zhou%2C+Hong&rft.au=Zheng%2C+Huaping&rft.au=Zhou%2C+Xikun&rft.date=2021-02-01&rft.pub=Taylor+%26+Francis&rft.issn=1554-8627&rft.eissn=1554-8635&rft.volume=17&rft.issue=2&rft.spage=529&rft.epage=552&rft_id=info:doi/10.1080%2F15548627.2020.1725381&rft.externalDocID=1725381
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1554-8627&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1554-8627&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1554-8627&client=summon